lundi 12 mars 2018

Onco Actu du 12 mars 2018

1. Biologie

Sir John Sulston, pioneering genome scientist, dies aged 75 [The Guardian]

3. Prévention

Is vitamin D really a cure-all – and how should we get our fix? [The Guardian]

5.10 Traitements - Essais

Targeted Therapy Larotrectinib Shows Promise in Early Trials, Regardless of Cancer Type [NCI]

5.12.5 Immunothérapies - Pharma

AstraZeneca provides update on MYSTIC trial timeline [AstraZeneca]

AstraZeneca sees pivotal lung cancer trial results later in 2018 [Reuters]

5.2 Pharma

MSKCC’s Maura Dickler to become Eli Lilly’s new late-stage cancer R&D lead [FierceBiotech]

5.3.4 Traitements - AMM (FDA, EMA,...)

EMA Recommends Extensions of Therapeutic Indications for Bosutinib [ESMO]

5.4 Traitements - Economie

Martin Shkreli has been sentenced. The drug industry is trying to get away scot-free [STAT]

You Hate Martin Shkreli. That's Sort Of The Problem [Forbes]

Martin Shkreli's Going Away, America's Drug-Price Problem Isn't [Bloomberg]

6. Lutte contre les cancers

Henrietta Lacks (1920-1951) [NY Times]

6.10.1 Politiques (USA)

Oncologist Jason Westin looks back—and ahead—after defeat in Texas primary [Science]

6.7.1 Bioinformatique

Google Cloud for Healthcare: new APIs, customers, partners and security updates [Google Cloud]

Google's Schmidt Tells HIMSS That AI Will Enable Precision Medicine, Won't Replace Doctors [Genome Web]

6.7.3 DMP

It's time we address the elephant in the room at every health care conference [CNBC]